Across TCGA pan-cancer cohorts, MIR4694 RNA differs between tumor and matched normal tissue in 1 of 18 cancer types tested, making tumor–normal expression one of MIR4694’s most consistent transcriptional readouts.
The strongest signal is observed in lung adenocarcinoma (LUAD), where MIR4694 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types MIR4694 is over-expressed in tumor.
LUAD are the cancer types where MIR4694 tumor–normal differential expression is most reproducible.